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Chromosomal instability in early cancer stages is
caused by stress on DNA replication. The molecular
basis for replication perturbation in this context is
currently unknown. We studied the replication
dynamics in cells in which a regulator of S phase
entry and cell proliferation, the Rb-E2F pathway, is
aberrantly activated. Aberrant activation of this
pathway by HPV-16 E6/E7 or cyclin E oncogenes
significantly decreased the cellular nucleotide levels
in the newly transformed cells. Exogenously supplied
nucleosides rescued the replication stress and DNA
damage and dramatically decreased oncogene-
induced transformation. Increased transcription of
nucleotide biosynthesis genes, mediated by ex-
pressing the transcription factor c-myc, increased
the nucleotide pool and also rescued the replica-
tion-induced DNA damage. Our results suggest a
model for early oncogenesis in which uncoordinated
activation of factors regulating cell proliferation leads
to insufficient nucleotides that fail to support normal
replication and genome stability.
INTRODUCTION
Oncogenesis drives cell proliferation by interfering with various
cellular pathways. One such pathway is the retinoblastoma
(Rb) E2F pathway (Rb-E2F), an important regulator of cell prolif-
eration. Rb is a key player in cell-cycle regulation, restricting cell
proliferation by direct inhibition of the E2F family of transcription
factors (van den Heuvel andDyson, 2008). One oncogene dereg-
ulating the Rb-E2F pathway is the human papillomavirus (HPV)
E7, which binds and degrades Rb. This degradation leads to
aberrant activation of the E2F family of proteins, which promotes
cell proliferation and DNA synthesis. HPV infection is the major
cause of cervical cancer in women.Another oncogene that aberrantly activates the Rb-E2F
pathway is cyclin E, which is overexpressed in many cancers,
including carcinomas, lymphomas, leukemias, and sarcomas
(Akli and Keyomarsi, 2003). Cyclin E regulates S phase entry
by Rb phosphorylation and inactivation, facilitating E2F release.
Overexpression of cyclin E greatly accelerates S phase entry in
cultured cells (Ohtsubo and Roberts, 1993).
Aberrant activation of the Rb-E2F pathway leads to the forma-
tion of DNA double-strand breaks (DSBs) and chromosomal
instability (Frame et al., 2006; Pickering and Kowalik, 2006).
This leads to senescence or apoptosis, providing a barrier to
cancer progression. In order to overcome this barrier, the high-
risk HPV expresses the E6 oncoprotein, which induces protea-
somal degradation of p53, thus avoiding cell-cycle arrest or
apoptosis. Hence, together, E6 and E7 enable proliferative
activity of HPV-infected cells (Duensing and Mu¨nger, 2004). In
cancers involving cyclin E overexpression, additional mutations
abrogating the DNA damage response are required to overcome
the apoptosis/senescence barrier (Gorgoulis et al., 2005).
Chromosomal instability is a hallmark feature of nearly all solid
tumors and adult onset leukemias. This instability develops at
early stages of cancer neoplasia and can be detected even in
premalignant lesions (Duensing and Mu¨nger, 2003; Klausner,
2002). Different mechanisms have been suggested to explain
this genome instability, including shortening of telomeres
(Plug-DeMaggio et al., 2004), defective DNA damage repair
(Duensing and Mu¨nger, 2002), oxidative stress (Bartkova et al.,
2010), and chromosomal segregation errors (Duensing et al.,
2000). These mechanisms contribute mainly to chromosomal
changes, which appear in more advanced stages of cancer
development (Gorgoulis et al., 2005). In early stages, the insta-
bility was found preferentially at fragile sites, genomic regions
sensitive to replication perturbation (Gorgoulis et al., 2005).
More recently, genomic instability in early cancer stages was
shown to be caused by stress on the DNA replication, conferred
by oncogene expression (Bartkova et al., 2006; Di Micco et al.,
2006). However, the molecular events leading to the formation
of replication stress, DSBs, and chromosomal instability shortly
after oncogene expression are still unclear.Cell 145, 435–446, April 29, 2011 ª2011 Elsevier Inc. 435
Here, we show that viral (HPV-16 E6/E7) or cellular (cyclin E)
oncogenes, leading to abnormal activation of the Rb-E2F
pathway, enforce cell proliferation with an insufficient pool of
nucleotides to support normal DNA replication. This leads to
replication perturbation, DNA damage, and genome instability.
Importantly, an exogenous supply of nucleosides rescues the
replication stress, decreases the replication-induced DNA
damage, and reduces transformation of the cells expressing
the oncogenes. We suggest that the low-nucleotide pool is
a result of an unbalanced activation of nucleotide biosynthesis
genes. We further show that activation of the cellular nucleotide
biosynthesis pathways increases the nucleotide pool and
rescues the replication-induced DNA damage. Altogether, our
study reveals that nucleotide insufficiency plays an important
role in the replication stress and genomic instability caused by
aberrant activation of the Rb-E2F pathway.
RESULTS
As a first step in investigating the early events leading to DNA
damage and genomic instability in cancer development, we
studied the effect of aberrant activation of the Rb-E2F pathway
by HPV-16 E6/E7 oncoproteins. For this, we used primary kera-
tinocytes derived from adult skin biopsies, which have a very
poor proliferation capacity ex vivo. The cells were infected with
a LXSN-based retroviral vector, which did not affect cell prolifer-
ation or DNA replication (Figures S1A and S1B available online).
Keratinocytes from the same donor were infected with the LXSN
vector containing the HPV-16 E6 and E7 viral genes. We verified
the expression of E6/E7 by RT-qPCR using primers for each of
these viral genes. Using quantitative real-time PCR (RT-qPCR),
we found that the expression level of E6 and E7 in these kerati-
nocyte cells was 2 times lower, compared to the level in
a cell line originating from HPV16-induced cervical cancer
(CaSki) (Figure S1C), showing that the E6/E7 expression in
keratinocytes is at physiological levels. As expected, E6 and
E7 transcripts were detected only in keratinocytes infected
with the E6/E7 vector and not in the primary keratinocytes of the
same donor (data not shown). Importantly, the E6/E7-expressing
cells continued to proliferate at least 100 days, indicating their
successful immortalization. These results show that E6/E7 genes
were expressed and enforced continuous proliferation of the
infected keratinocytes. In order to investigate early events
induced by E6/E7 expression, the experiments were performed
in newly transformed cells 2–6 weeks following E6/E7 infection
and before anaphase bridges and micronuclei are visible.
HPV-16 E6/E7 Expression Generates Stress
on the Cellular DNA Replication
In order to investigate the effect of HPV on the cellular DNA repli-
cation, we took advantage of the DNA combing approach, which
enables replication analysis on single DNAmolecules. The newly
synthesized DNA labeled with IdU and CldU was detected by
fluorescent antibodies (green and red, respectively) (Figure 1A).
The replication dynamics were studied in normal primary kerati-
nocytes obtained from adult skin samples of two individuals
and in keratinocytes from the same donors expressing E6/E7
proteins for 2–6 weeks.436 Cell 145, 435–446, April 29, 2011 ª2011 Elsevier Inc.First, we analyzed the effect of E6/E7 expression on the
cellular DNA replication fork rate (Figure 1B). The results show
a dramatic decrease in the mean replication rate, from 1.3 ±
0.06 Kb/min (n = 130) in human primary keratinocytes to 0.75 ±
0.05 Kb/min (n = 144) in cells expressing E6/E7 (p < 1.5 3
1014). Importantly, a dramatic increase in the percentage of
very slow forks was observed following E6/E7 expression (Fig-
ure 1B). Similar results were obtained in the analysis of keratino-
cytes from another donor (Figure S2A). These results indicate
that, shortly following expression of the viral E6/E7 proteins,
there is a significant decrease in DNA fork progression rate.
The two replication forks emerging from the same origin tend
to exhibit the same replication rate (Conti et al., 2007). However,
under replication stress conditions, perturbed fork progression
might lead to asymmetric progression of the outgoing forks (Di
Micco et al., 2006). Hence, we compared the progression of
the left and right forks emerging from the same origin in primary
and E6/E7-expressing keratinocytes from the same donor. As
previously suggested (Conti et al., 2007), a symmetric progres-
sion of the two forks was considered when the ratio of left and
right forks was > 0.75. The analysis revealed a significantly
decreased symmetry between the right and left fork progression
in the E6/E7-expressing cells compared to the primary cells
(p < 3 3 106). In the primary replicating cells, the mean ratio
was 0.81 ± 0.01 (n = 156), and only 23% of the replication
bubbles showed asymmetric dynamics. In contrast, in the E6/
E7-expressing cells, a poor symmetry was found with a mean
ratio of 0.71 ± 0.01 (n = 194), and 47% of the origins showed
asymmetric replication progression (Figure 1C and Figure S2C).
This indicates that, a short time following E6/E7 expression, the
processivity of the DNA replication machinery is perturbed.
Previous studies indicate that slow fork progression correlates
with increased number of active origins (Anglana et al., 2003;
Courbet et al., 2008; Ge et al., 2007). Hence, we studied the
effect of E6/E7 proteins on the origin density by measuring the
distance between two adjacent origins. The results showed
that the mean origin distance in the primary keratinocytes
was 187 ± 26 Kb (n = 67), whereas in the E6/E7-expressing
keratinocytes, it was significantly shorter, only 121 ± 24 Kb
(n = 93) (p < 5 3 105). Furthermore, a dramatic increase in the
fraction of molecules with very short origin distance was
observed following E6/E7 expression (Figure 1D). Similar results
were obtained from other donors (Figure S2B and data not
shown). These results indicate that E6/E7 expression leads to
activation of an increased number of origins. Altogether, the
replication dynamic results show that, in newly transformed
E6/E7-expressing cells, the host cell DNA replication is dramat-
ically perturbed.
Chronic HPV-16 E6/E7 Expression Causes a Change
in the Programmed Activation of Dormant Origins
Dormant origins activation could occur in S phase to enable
completion of DNA synthesis in perturbed replicons (Ge et al.,
2007). In this case, a difference in the firing time of adjacent
origins is expected. Alternatively, dormant origins could already
be licensed in G1 as a cellular response to chronic replication
stress (Courbet et al., 2008). In this case, a synchronic replication
time between adjacent origins is expected.
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Figure 1. Replication Dynamics in Primary and HPV-16 E6/E7-Expressing Keratinocytes
(A) Example of a single combed DNA molecule labeled with IdU (green) and CldU (red), showing replication from two adjacent origins. Green arrows, orientation
and length of fork progression.
(B) Fork rate (Kb/min) distribution. White bars, primary keratinocytes (n = 130); black bars, keratinocytes expressing E6/E7 (n = 144).
(C) Progression ratio between left and right forks emerging from the same origin. Primary keratinocytes (n = 156); keratinocyte-expressing E6/E7 (n = 194).
(D) Origin density distribution. White bars, primary keratinocytes (n = 67); black bars, keratinocytes expressing E6/E7 (n = 93).
(E) Differences in firing time between adjacent origins. The groups represent different relative firing time in minutes. Primary keratinocytes (n = 50); keratinocytes
expressing E6/E7 (n = 89).
See also Figure S1, Figure S2, Table S1, and Table S2.In order to study the dynamics of origin firing as a result of the
viral E6/E7 expression, we estimated the relative firing time of
every two adjacent origins in the analyzed fibers (Figure S2D).
In primary keratinocytes, the mean difference in firing time
between two adjacent origins was 26 ± 3.1 min (n = 50). No
significant difference (p > 0.95) in firing time was observed in
primary keratinocytes expressing E6/E7 (mean of 26 ± 3.8 min
[n = 89]) (Figure 1E). These results support the possibility of pro-
grammed activation of dormant origins in G1 prior to the replica-
tion initiation in S phase.
HPV-16 E6/E7 Expression Leads to Loss
of Heterozygosity at Common Fragile Sites
Chromosomal instability can lead to loss of heterozygosity
(LOH). Previous studies have demonstrated that, in early stagesof cancer development, the instability occurs preferentially in
genomic regions that are sensitive to replication stress, defined
as fragile sites (Bartkova et al., 2005; Di Micco et al., 2006;
Gorgoulis et al., 2005; Tsantoulis et al., 2008). Later in cancer
development, the instability is found along the entire genome
(Gorgoulis et al., 2005). LOH analysis was performed using
single-nucleotide polymorphism (SNP) array. The heterozygosity
in primary keratinocytes was compared to that in keratinocytes
expressing E6/E7 for 100 or 250 days.
The results showed that, 100 days following expression of E6/
E7, 1.4% of the informative SNPs in the entire genome revealed
LOH, indicating that E6/E7 expression leads to genome
instability. The instability is dramatically increased with time,
and after 250 days, 17% of the informative SNPs showed
LOH. In the fragile sites, the most replication-sensitive sitesCell 145, 435–446, April 29, 2011 ª2011 Elsevier Inc. 437
(FRA3B,FRA16D,andFRA7G) revealed4.1%LOHafter100days,
which is significantly higher than found in the entire genome (p <
0.0024). After 250 days, even less-sensitive fragile sites showed
significantly higher LOH frequency (p < 93 104) (Table S1), indi-
cating a preferential instability along common fragile sites. In
several fragile sites, a dramatic LOH of 31% (FRA11E) and 50%
(FRA9G) was found. These results indicate that, in early stages
of cancer development, the replication stress caused by E6/E7
expression leads to increased genomic instability at the most
sensitive fragile sites, followed by instability at other fragile
regions. As previously shown, in later stages of cancer develop-
ment, amassivegenomic instability is found in fragile andnonfrag-
ile regions in the genome (Gorgoulis et al., 2005).
Copy number variation (CNV) analysis of the same experiment
revealed after 100 days a loss of chromosome 8p and a gain of
the entire chromosome 20 in the E6/E7-expressing cells. Inter-
estingly, chromosome 20q amplification is recurrently observed
in cervical carcinoma cells (Tsantoulis et al., 2008). Analysis of
cells expressing E6/E7 for 250 days revealed additional amplifi-
cations, which frequently appear in cervical cancer (Table S2),
mainly in chromosomes 8q, 7p, and 11q (Harris et al., 2003).
Overall, the LOH and CNV results indicate that similar instability
events are found in ex vivo and in vivo cell proliferation and trans-
formation processes.
A Low-Nucleotide Pool in Cells Expressing HPV-16
E6/E7 Leads to Replication Stress, Genome
Instability, and Tumorigenicity
The replication dynamics is largely determined by the size and
balance of the nucleotide pool (Anglana et al., 2003; Courbet
et al., 2008). Hence, we studied the effect of E6/E7 on the nucle-
otide pool using the high-performance liquid chromatography
(HPLC) method. Our results show a 2- to 5-fold decrease in the
level of the four dNTPs following E6/E7 expression for 2–4 weeks
(Figure 2A and Table S3A). Interestingly, a 2-fold decrease was
also found in the level of all ribonucleotides (rNTPs) (Figure S3A
and Table S3B), indicating that the nucleotide biosynthesis is
disturbed upstream in the pathway. These results suggest that
the replication perturbation and genomic instability found in the
E6/E7-expressing cells result from an insufficient nucleotide
pool required to support extensive proliferation.
In order to test this hypothesis, we analyzed whether exoge-
nous supply of nucleosides can modulate the replication
dynamics in E6/E7-expressing cells. For this, primary keratino-
cytes and keratinocytes expressing E6/E7 for 2–4 weeks
were grown for 48 hr in a medium supplemented with the four
nucleosides (A, U, C, and G). Evaluating the replication
dynamics using DNA combing revealed that exogenous supply
of nucleosides to keratinocytes expressing E6/E7 led to
a dramatic increase in the replication rate to an average of 1.1 ±
0.06 Kb/min (n = 155), as compared to 0.75 ± 0.05 Kb/min (n =
150) (p = 8 3 107) in the same cells grown in a normal medium
(Figure 2B). Moreover, the average replication rate after supply
of exogenous nucleosides reached 90% of the mean fork rate
in primary keratinocytes. Similar results were obtained using
cells from another donor (Figure S3B). It is important to note
that exogenous supply of nucleosides had no effect on the
replication rate and interorigin distances of normal primary ker-438 Cell 145, 435–446, April 29, 2011 ª2011 Elsevier Inc.atinocyte cells (1.2 ± 0.04 Kb/min [n = 83]; 129 ± 11 Kb [n = 42])
(Figures S3D and S3E).
Subsequently, we studied the effect of exogenous nucleosides
supply on the interorigin distances. In accordance with the repli-
cation rate, E6/E7-expressing cells supplied with nucleosides
showed a dramatic increase in the average interorigin distance
compared to that of E6/E7 cells grown in a normal medium,
165 ± 12 Kb (n = 89) and 120 ± 10 Kb (n = 93) (p = 8 3 107),
respectively.WhereasE6/E7-expressing keratinocytes exhibited
in 45% of the cases an origin distance < 80 Kb, after supply of
exogenous nucleosides, the fraction of these distances was
only 22% (Figure 2C). Similar results were obtained using cells
from another donor (Figure S3C).
Our LOH results revealed that replication-induced DSBs are
generated following E6/E7 expression. Hence, we further inves-
tigated whether exogenous supply of nucleosides can decrease
these replication-induced DSBs. For this, we analyzed the
formation of gH2AX foci, known to localize at DSBs (Rogakou
et al., 1998). Immunofluorescence analysis using antibodies
directed against gH2AX was performed in cells expressing
E6/E7 for 2–6weeks, grown in a normal medium and in amedium
supplemented with exogenous nucleosides. The analysis
showed a significant decrease in the number of gH2AX foci
following exogenous nucleoside supply compared to cells grown
in a normal growth medium, 4 ± 1 (n = 70) and 9 ± 1.1 (n = 52) foci
per nucleus, respectively (Figure 2D) (p < 73 104). Importantly,
a high level of gH2AX foci (>10 foci per nuclei) was observed in
40% of the nuclei from cells expressing E6/E7 grown in a normal
keratinocytemedium, whereas such a high focus level was found
in only 13%of the cells supplemented with nucleosides for 48 hr.
Furthermore, 70% of supplemented nuclei revealed a very low
focus level (0–2), similar to that found in > 90% of primary
keratinocytes.
Keratinocyte cells expressing the full-length HPV-16 genome
(F1 cells) for 6 weeks revealed replication stress and DNA
damage similar to that observed in cells expressing only HPV-
16 E6/E7 (Figures S4A–S4C). Importantly, both the replication
stress andDNAdamage in these cells could be rescued by exog-
enous supply of nucleosides (Figures S4A–S4C), indicating that
the replication-induced DNA damage indeed results from the
expression of the HPV-16 E6/E7 oncogenes and is not affected
by expression of other viral proteins.
We then studied whether the nucleotide pool can modulate
oncogene-induced cell transformation. We tested this using
the common in vitro transformation assay that measures
anchorage-independent growth in soft agar. The cells grown in
the normal medium showed a significant (p = 0.02) anchorage-
independent growth in soft agar, whereas cells grown in the
nucleoside-enriched medium formed rare and small colonies:
25.3 ± 6 and 2.3 ± 1 colonies per plate, respectively (n = 3) (Fig-
ure 2E). It is important to note that exogenous supply of nucleo-
sides to E6/E7-expressing cells did not affect cell proliferation
(Figure S4D), indicating that the decrease in soft agar colony
formation, following exogenous nucleoside supply, is not due
to a decrease in the rate of cell proliferation.
Altogether, our results show that, following E6/E7 expression,
a low-nucleotide pool causes replication perturbation, leading to
genomic instability and increased tumorigenic potential.
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Figure 2. The Effect of an Exogenous Supply of Nucleosides on the Replication Dynamics, DNA Damage, and Transformation in HPV-16
E6/E7-Expressing Cells
(A) The nucleotide levels in keratinocyte cells expressing E6/E7 normalized to the level in primary cells of the same donor. *p < 0.05. The levels are expressed as
mean fold change ± SEM (n = 3).
(B) Fork rate (Kb/min) distribution. White bars, primary keratinocytes (n = 130); black bars, keratinocytes expressing E6/E7 (n = 150); gray bars, keratinocytes
expressing E6/E7 grown for 48 hr with exogenous supply of nucleosides (n = 155).
(C) Origin density (Kb) distribution. White bars, primary keratinocytes (n = 67); black bars, keratinocytes expressing E6/E7 (n = 93); gray bars, keratinocytes
expressing E6/E7 grown for 48 hr with exogenous supply of nucleosides (n = 89).
(D) (Left) Examples of nuclei with gH2AX foci following expression of E6/E7 grown in a normal medium (E6/E7) and in a medium supplied with exogenous
nucleosides (E6/E7+AUCG). The nuclei were stained with DAPI. (Right) Percent of nuclei with the indicated number of gH2AX foci. Primary keratinocyte cells
(n = 51); keratinocytes expressing E6/E7 (n = 52); keratinocytes expressing E6/E7 supplied with exogenous nucleosides (n = 70).
(E) (Left) Examples of anchorage-independent growth in soft agar. (Right) Mean number of colonies per a soft agar plate. Cells expressing E6/E7; cells expressing
E6/E7 supplied with exogenous nucleosides. The number of colonies per plate is expressed as mean ± SEM (n = 3).
See also Figure S3 and Figure S4, and Table S3.
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Figure 3. The Effect of an Exogenous Supply of Nucleosides on the Replication Dynamics and DNA Damage of BJ Cells Expressing Cyclin E
(A) rNTP pool following cyclin E expression in BJ cells. The levels are expressed as mean fold change ± SEM (n = 4).
(B) Fork rate distribution (Kb/min). White bars, BJ cells (n = 163); black bars, BJ expressing cyclin E (n = 165); gray bars, BJ expressing cyclin E grown for 48 hr with
exogenous supply of nucleosides (n = 173).
(C) Origin density distribution (Kb). White bars, BJ cells (n = 45); black bars, BJ expressing cyclin E (n = 34); gray bars, BJ expressing cyclin E grown for 48 hr with
exogenous supply of nucleosides (n = 46).
(D) Percent of nuclei with the indicated number of gH2AX foci. BJ cells (n = 57); BJ expressing cyclin E (n = 110); BJ expressing cyclin E grown for 48 hr with
exogenous supply of nucleosides (n = 64).
See also Figure S5 and Table S3.A Low-Nucleotide Pool in Cells Expressing Cyclin E
Leads to Replication Stress and Genome Instability
We further investigated whether aberrant activation of the Rb-
E2F pathway by cellular oncogenes also leads to an insufficient
nucleotide pool, required for normal DNA replication. For this, we
expressed the human cyclin E, which is frequently overex-
pressed in human precancerous and cancerous lesions. Cyclin
E has a major role in the control of G1/S transition as it mediates
Rb phosphorylation, which inactivates Rb and facilitates E2F
release. Like the viral E7 oncogene, cyclin E activity leads to
G1 shortening and forces cells to enter S phase (Hwang and
Clurman, 2005).
Using retroviral infection, we expressed the human cyclin E in
human primary fibroblasts from healthy donors or immortalized
foreskin fibroblasts (BJ cells). The expression of cyclin E was
verified by RT-qPCR and western blot (Figure S5A). First, we
measured the nucleotide levels in BJ cells expressing cyclin E
or an empty control vector for 2–4 weeks, before senescence
prevents cell divisions in the tissue cultured cells. The results440 Cell 145, 435–446, April 29, 2011 ª2011 Elsevier Inc.revealed a 50% decrease (p = 0.03) in the rNTP pool following
cyclin E expression (Figure 3A and Table S3D). Importantly, the
dNTP levels decreased dramatically to a level that is below
detection (Table S3C). A similar decrease was found in primary
fibroblast cells (Table S3E and data not shown).
Next, we analyzed the effect of exogenously supplied nucleo-
sides on the replication dynamics of cells expressing cyclin E.
The analysis revealed a significant perturbation in the replication
dynamics following cyclin E expression. Themean fork rate in BJ
cells expressing the empty vector was 1.5 ± 0.03 Kb/min (n =
163), whereas following cyclin E expression, the rate was signif-
icantly slower (1.0 ± 0.03 Kb/min, n = 165) (p < 3 3 1028). The
fraction of very slow forks (<0.75 Kb/min) was 10 times higher
(Figure 3B). Exogenous supply of the four nucleosides for 48 hr
increased fork rate to 1.3 ± 0.03 Kb/min (n = 173), which consti-
tutes an 87% recovery (p = 6 3 106). Similar results were
found in primary fibroblasts from an adult donor expressing the
cyclin E oncogene. Fork progression rate decreased from 1.2 ±
0.06 Kb/min (n = 125) in the primary cells to 0.8 ± 0.06 Kb/min
Table 1. The Significant Upregulated Pathways following the Expression of Cyclin E, c-Myc, or Coexpression of Both Genes in BJCells
Term P Value Fold Enrichment FDR
Cyclin E Cell cycle 1.42 3 1018 8.693907512 1.52 3 1015
DNA replication 2.98 3 1015 16.8358209 3.20 3 1012
Oocyte meiosis 1.32 3 108 5.962686567 1.4 3 105
Systemic lupus erythematosus 5.45 3 106 5.183660644 0.00580449
Progesterone-mediated oocyte maturation 1.08 3 105 5.34784899 0.011501479
c-Myc DNA replication 7.02 3 1015 10.63095238 8.34 3 1012
Cell cycle 4.50 3 1013 4.953161593 5.36 3 1010
Pyrimidine metabolism 6.07 3 1010 4.876691729 7.24 3 107
Purine metabolism 4.18 3 109 3.68627451 4.98 3 106
Oocyte meiosis 4.30 3 106 3.543650794 0.005126052
Progesterone-mediated oocyte maturation 1.36 3 105 3.791596639 0.016195283
Cyclin E c-Myc DNA replication 2.12 3 1017 12.87671233 2.45 3 1014
Cell cycle 2.89 3 1011 4.939591287 3.34 3 108
Pyrimidine metabolism 3.78 3 1011 5.611535689 4.37 3 108
Purine metabolism 8.97 3 1010 4.090249799 1.04 3 106
Oocyte meiosis 1.17 3 105 3.648401826 0.013464979
Nucleotide excision repair 1.19 3 105 5.794520548 0.01377895
Mismatch repair 3.33 3 105 8.061941632 0.038459564
Pathways discussed in the text are set in italics.(n = 62) (p < 2 3 107). Exogenous nucleoside supply increased
the fork rate to 1.1 ± 0.05 Kb/min (n = 80), a 92% recovery (p =
0.0002) (Figure S5B).
Subsequently, we analyzed the interorigin distance. The anal-
ysis in BJ cells revealed a significant decrease from 289 ± 25 Kb
(n = 45) to 168 ± 14 Kb (n = 34) following cyclin E expression
(p < 2.5 3 105). Importantly, exogenous nucleoside supply
increased the distance to 237 ± 14 Kb (n = 46) (p < 43 104) (Fig-
ure 3C). Similar results were found in primary fibroblasts. The
interorigin distance decreased from 172 ± 12 Kb (n = 47) to
127 ± 15 Kb (n = 27) (p = 0.01) following cyclin E expression,
and exogenous nucleoside supply increased the interorigin
distance to 159 ± 11 (n = 42) (Figure S5C). These results indicate
that cyclin E overexpression leads to replication stress that can
be rescued by supply of exogenous nucleosides.
Next, we studied the effect of exogenous nucleoside supply on
the DSBs induced by cyclin E overexpression. The analysis
revealed a significant increase in the level of DSBs following
cyclin E expression, as measured by gH2AX foci: 7.7 ± 1.5 foci/
cell (n = 35) to 18.5 ± 1.9 foci/cell (n = 39) in fibroblasts expressing
cyclin E (p = 53 105) (Figure S5D) and 1.2 ± 1.5 foci/cell (n = 57)
to 27 ± 2.5 (n = 110) foci/cell in BJ cells expressing cyclin E
(p = 1 3 1015) (Figure 3D). As found in E6/E7-expressing cells,
exogenous nucleoside supply decreased the extent of DNA
damage in the cyclin E expressing cells to 3.5 ± 2.1 foci/cell in
BJ cells (n = 64, p = 8 3 1013) and 3.3 ± 0.8 foci/cell in primary
fibroblasts (n = 44) (p = 5 3 109) (Figure 3D and Figure S5D).
Altogether, these results indicate that activation of the Rb-E2F
pathway by cellular or viral oncogenes results in an insufficient
nucleotide pool, leading to replication stress and DNA damage.
Importantly, this replication-induced DNA damage can be
rescued by exogenous supply of nucleosides.Activation of the Nucleotide Biosynthesis Pathways
Rescues the Replication Stress and Genome Instability
We aimed to further understand the molecular basis for the low-
nucleotide pool in cells enforced to proliferate by oncogene
expression. Cell proliferation depends on coordinated activation
of the different nucleotide metabolic genes (Liu et al., 2008;
Mannava et al., 2008), which are tightly regulated by the tran-
scription factors and master regulators of cell proliferation.
Hence, we hypothesized that the low-nucleotide pool in onco-
gene-expressing cells results from insufficient activation of the
nucleotide biosynthesis pathways. In order to test this hypoth-
esis, we performed unbiased whole-transcriptome analysis of
BJ cells in comparison to BJ cells expressing cyclin E. The anal-
ysis revealed that the most significantly upregulated pathways
pertain to cell cycle (p = 1.52 3 1015) and DNA replication
(p = 3.23 1012) (Table 1). Importantly, cyclin E expression failed
to upregulate the nucleotide biosynthesis pathways. The expres-
sion levels of eight important genes in the purine and pyrimidine
biosynthesis pathways—PPAT, DHODH, ADSL, CTPS, NME1,
IMPDH2, TS, and RRM2—are shown in Figure S6A. We further
verified these results using RT-qPCR in both BJ and keratinocyte
cells compared to cells expressing cyclin E or E6/E7, respec-
tively. The results revealed that, following oncogene expression,
the level of most genes was not altered (six and seven genes,
respectively) (Figure 4A, black bars, and Figure S6B). These
results suggest that Rb-E2F aberrant activation enforces cell
proliferation but fails to activate the nucleotide biosynthesis
pathway, leading to insufficient pool of nucleotides required for
normal replication.
Nucleotide biosynthesis was recently found to be regulated by
c-Myc, amaster regulator ofmanygenes that are involved inDNA
replication and cell proliferation (Liu et al., 2008; Mannava et al.,Cell 145, 435–446, April 29, 2011 ª2011 Elsevier Inc. 441
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Figure 4. The Effect of c-myc Expression on the Expression of the Nucleotide Biosynthesis Genes, Nucleotide Pools, Replication Dynamics,
and DNA Damage
(A) Fold change in the expression level of c-Myc targets from the nucleotide biosynthesis pathways. Black bars, expression of E6/E7 normalized to the level in
primary keratinocytes; gray bars, expression of c-myc in E6/E7-expressing keratinocytes normalized to the level in cells expressing only E6/E7. The levels are
expressed as mean fold change ± SEM (n = 3).
(B) Nucleotide levels in primary keratinocytes, keratinocytes expressing E6/E7, and keratinocytes coexpressing E6/E7 and c-myc. *p < 0.05. The levels are
expressed as mean fold change ± SEM (n > 3).
(C) Fork rate distribution (Kb/min). Black bars, keratinocytes expressing E6/E7 (n = 173); gray bars, keratinocytes expressing E6/E7 with enhanced nucleotide
biosynthesis by c-Myc (n = 175).
(D) Percent of nuclei with the indicated number of gH2AX foci in cells expressing E6/E7 (n = 80) and in keratinocytes expressing E6/E7 with enhanced nucleotide
biosynthesis by c-Myc (n = 103).
See also Figure S6.2008). However, the expression of c-myc is not altered following
E6/E7 or cyclin E expression (Figure 4A, black bars, and Fig-
ure S6B) (Gross-Mesilaty et al., 1998). Whole-transcriptome
analysis of BJ cells expressing retroviral vector containing
the human c-myc cDNA for 3 weeks revealed, as expected,
that the most significantly upregulated pathways are DNA
replication (p = 8.343 1012), cell cycle (p = 5.363 1010), pyrim-
idine (p = 7.243 107), and purine (p = 4.983 106) metabolism
(Table 1 and Figure S6A). It is worth noting that primary keratino-
cytes expressing c-myc are unable to proliferate; hence, the
whole-transcriptome analysis could not be performed in these
cells.
It is important to note that Rb-E2F aberrant activation fails
to activate many important genes from the nucleotide biosyn-
thesis pathways, whereas c-myc significantly upregulates the
purine and pyrimidine metabolism pathways. Hence, it was
interesting to study the effect of upregulation of nucleotide
biosynthesis pathways by increased c-myc expression in aber-
rantly activated Rb-E2F cells. For this, we expressed c-myc in442 Cell 145, 435–446, April 29, 2011 ª2011 Elsevier Inc.BJ and keratinocyte cells expressing cyclin E or E6/E7 for
2–4 weeks. Whole-transcriptome analysis in the BJ cells coex-
pressing cyclin E and c-myc revealed that the most significantly
activated pathways are DNA replication (p = 2.45 3 1014), cell
cycle (p = 3.343 108), pyrimidine (p = 4.373 108), and purine
metabolism (p = 1.04 3 106) (Table 1 and Figure S6A). These
results indicate that c-myc expression upregulates the nucleo-
tide biosynthesis in cells forced to proliferate by aberrant activa-
tion of the Rb-E2F pathway. We verified these results using
RT-qPCR analysis in keratinocyte cells coexpressing E6/E7
and c-myc. The analysis revealed a 2- to 5-fold increase in the
transcript levels of important nucleotide biosynthesis c-Myc
targets (IMPDH2, NME1, ADSL, DHODH, CTPS, PPAT, RRM2,
and TS), compared to levels in cells from the same donor ex-
pressing only E6/E7 for the same time period (Figure 4A, gray
bars). We further tested whether this activation of biosynthesis
genes can modulate the nucleotide levels in the E6/E7-express-
ing keratinocytes. Indeed, HPLC analysis revealed 3.5-fold
increase in the levels of dATP, dTTP, and dCTP in cells
expressing E6/E7 upon activation of the nucleotide biosynthesis
pathways (Figure 4B and Table S3).
We then analyzed the replication dynamics in these cells. The
results showed a significant increase in the replication rate,
from 0.86 ± 0.06 Kb/min (n = 173) in the E6/E7-expressing cells
to 1.14 ± 0.05 Kb/min (n = 175) in the E6/E7- and c-myc-ex-
pressing cells (p < 4 3 108) (Figure 4C). Activation of the
nucleotide biosynthesis in BJ cells overexpressing cyclin E
also led to a higher fork progression rate (from 0.84 ± 0.04
Kb/min [n = 72] to 0.97 ± 0.03 Kb/min [n = 104] [p = 0.005])
(Figure S6C).
We further hypothesized that the increased levels of the
nucleotides and the rescue of the replication stress would lead
to a decrease in the DSBs in these cells. To test this, we
measured gH2AX foci formation. The results show a highly
significant (p < 5 3 1024) decrease in gH2AX foci formation in
keratinocytes expressing E6/E7, in which nucleotide biosyn-
thesis was upregulated by c-Myc (4.4 ± 0.6 foci per cell, n =
103) compared to cells expressing only the E6 and E7 genes
(19.6 ± 1 foci per cell, n = 80) (p < 53 1024) (Figure 4D). BJ cells
expressing cyclin E revealed similar results. Upregulation of the
nucleotide biosynthesis led to a decrease in gH2AX foci (1.3 ±
0.3 foci per cell, n = 48) as compared to the control cells
expressing cyclin E (3.0 ± 0.5 foci per cell, n = 64) (p < 0.009)
(Figure S6D). It is important to note that c-Myc activates a large
number of genes; hence, additional effects of c-Myc cannot be
excluded.
Another mechanism that may lead to a low-nucleotide pool
in cells expressing E6/E7 oncoproteins is E6-mediated p53
inactivation, which inhibits the expression of the ribonucleotide
reductaseM2 B (RRM2B) gene. RRM2B is required for deoxynu-
cleotide biosynthesis during DNA repair (Kimura et al., 2003;
Tanaka et al., 2000). In order to test this possibility, we infected
keratinocyte cells expressing E6/E7 for 3 weeks with a retroviral
vector containing the human RRM2B cDNA. First, we verified
the RRM2B expression using RT-qPCR (Figure S6E). We then
analyzed the effect of RRM2B expression on the replication
dynamics. Our results show no effect of RRM2B expression on
the replication stress caused by the E6/E7 expression. In primary
keratinocytes, the mean replication rate was 1.2 ± 0.04 Kb/min
(n = 169), and the mean interorigin distance was 132 ± 8 Kb
(n = 67). Following 3 weeks of E6/E7 expression in cells from
the same donor, the replication rate was 0.54 ± 0.2 Kb/min
(n = 161), and the interorigin distance was 69 ± 4 Kb (n = 94).
In cells expressing E6/E7 and RRM2B, the mean rate was
0.59 ± 0.04 Kb/min (n = 60), and the mean interorigin distance
was 79 ± 7Kb (n = 32). These results indicate that the RRM2B
expression did not rescue the replication stress conferred by
the expression of the E6/E7 oncogenes (Figures S6F and S6G).
Aberrant activation of the Rb-E2F pathway by cyclin E does not
lead to p53 degradation; hence, it seems unlikely that RRM2B
plays an important role in the mechanism leading to a low-nucle-
otide pool in these cells.
In summary, our results show that activation of the Rb-E2F
pathway fails to activate many of the nucleotide biosynthesis
genes. Upregulation of the nucleotide biosynthesis pathways
increases the nucleotide pool, rescues the replication stress,
and decreases the DNA damage.DISCUSSION
Here, we show that the basis for genome instability induced by
oncogenes activating the Rb-E2F pathway is uncoordinated S
phase entry, leading to insufficient factors required for normal
DNA replication. We revealed that cells are forced to proliferate
with an insufficient pool of nucleotides to support normal DNA
replication. Under these conditions, the replication machinery
fails to achieve regular rate and processivity, resulting in DNA
damage and genome instability.
A great effort has been made in the last decade to understand
themechanisms leading to genomic instability in cancer develop-
ment. Different models have suggested that this instability is
caused by shortening of telomeres (Plug-DeMaggio et al.,
2004), hypoxia (Coquelle et al., 1998), defective DNA damage
repair (Duensing and Mu¨nger, 2002), chromosomal segregation
errors (Duensing et al., 2000), abrogated mitotic checkpoints
(Thompson et al., 1997), and reactive oxygen species (Klaunig
and Kamendulis, 2004). More recently, oncogene-induced DNA
replication stress was suggested as a model (Halazonetis et al.,
2008). According to this model, the mechanism by which onco-
genes induce genomic instability in early stages of cancer
development is by causing replication stress leading to DNA
double-strand breaks. However, the molecular basis for this
oncogene-enforced replication stress remained largely unknown.
In our study, we investigated the mechanisms leading to DNA
damage in cells expressing the HPV-16 viral oncogenes E6/E7 or
the cellular oncogene cyclin E, both activating the Rb-E2F
pathway, amaster regulator of cell proliferation and DNA replica-
tion. Our results show that abnormal activation of the Rb-E2F
pathway by viral or cellular oncogenes leads to perturbed
progression of the replication forks and a poor symmetry
between forks emerging from the same origin (Figures 1B and
1C, Figure 3B, Figure S2A, and Figure S5B). This indicates
a poor processivity of the replication machinery, which leads to
replication fork collapse and DSBs (Figure 2D, Figure 3D, and
Figure S5D). The LOH analysis provides further evidence for per-
turbed replication by showing preferential instability at common
fragile sites, known to be sensitive to replication stress condi-
tions (Tsantoulis et al., 2008).
Previous studies showed the importance of the nucleotide
pool for normal DNA replication (Anglana et al., 2003; Courbet
et al., 2008). Hydroxyurea, an inhibitor of ribonucleotide reduc-
tase, lowers the dNTP pool and leads to slow DNA replication
rate (Anglana et al., 2003), short interorigin distance (Ge et al.,
2007), formation of DSBs (Saintigny et al., 2001), and expression
of fragile sites (Yan et al., 1987). Our results show that the nucle-
otide pool is reduced dramatically following expression of the
Rb-E2F-activating oncogenes (Figure 2A, Figure 3A, and Table
S3). Furthermore, an increase of the nucleotide pool rescued
the perturbed replication and the replication-induced DNA
damage in the oncogene-expressing cells (Figure 2, Figure 3,
Figures S3B and S3C, Figures S4A–S4C, and Figures S5B–
S5D). Importantly, exogenous nucleoside supply decreased
the anchorage-independent growth of the cells in soft agar (Fig-
ure 2E), suggesting reduced tumorigenic potential. Altogether,
our study indicates that induction of nucleotide synthesis by
oncogene-induced Rb-E2F expression is insufficient to supportCell 145, 435–446, April 29, 2011 ª2011 Elsevier Inc. 443
Cancer development
Figure 5. A Model for the Events Leading to Genomic Instability in Early Stages of Cancer Development
Oncogene expression forces cell proliferation by aberrant activation of cell-cycle regulators (Rb-E2F). Insufficient activation of the nucleotide biosynthesis
pathways results in a low-nucleotide pool that fails to support normal DNA replication. This leads to replication stress and promotes genomic instability during
early stages of cancer development. Additional factors contribute to genomic instability in different stages of tumorigenesis, such as reactive oxygen species
(ROS), telomere loss, hypoxia, abrogated mitotic checkpoints, and loss of the DNA damage response (DDR).the extensive proliferation of the cells, leading to replication-
induced DNA damage and increased tumorigenicity.
As previously suggested, the nucleotide pool size may modu-
late the replication in two distinct ways. It can activate dormant
origins during S phase (Ge et al., 2007), leading to asynchronous
origin firing. Alternatively, a poor nucleotide pool can determine
origin choice in G1, when origins are committed to become
active during S phase. Recently, Courbet et al. (2008) studied
the replication dynamics of cells exposed to aphidicolin, an
inhibitor of DNA polymerase a and d that affects the replication
rate in S phase. Using DNA combing, they revealed an asynchro-
nous firing of adjacent origins, as expected by the first model
(Ge et al., 2007). Here, we demonstrate a modulation of origin
firing in pre-S phase. We suggest that, under a chronic exposure
to a low-nucleotide pool, the cells compensate for the DNA repli-
cation stress by determining an increased origin density during
G1, rather than by activating the dormant origins during S phase
(Figure 1E).
Oncogenic activation of the Rb-E2F pathway by cyclin E or
HPV-16 E6/E7 causes upregulation of many genes involved in
cell proliferation and DNA replication, among which are many
E2F targets (Garner-Hamrick et al., 2004; Hwang and Clurman,
2005). Our results (Figure 4A, Figures S6A and S6B, and Table
1) suggest that the low-nucleotide pool in the cells results from
uncoordinated activation of the nucleotide biosynthesis path-
ways and cell cycle. Recently, it was shown that c-Myc is an
important regulator of nucleotide biosynthesis and that its
expression increases the nucleotide levels and cell proliferation
(Liu et al., 2008; Mannava et al., 2008). Indeed, coexpression
of cyclin E and c-myc revealed that the most significantly upre-
gulated pathways are cell cycle and DNA replication, as well as
purine and pyrimidine metabolism (Table 1, Figure 4A, and
Figures S6A and S6B). This leads to an increased nucleotide
pool, resulting in a rescue of the replication stress and DNA
damage in these cells (Figure 4B and Table S3).
Altogether, we suggest that activation of the Rb-E2F pathway
by cellular or viral oncogenes leads, in early stages of cancer
development, to a change in the transcription of many genes
involved in cell-cycle control, forcing cell proliferation and DNA
replication. This leads to an uncoordinated entry to S phase,
with aberrant activation of the nucleotide biosynthesis pathways.444 Cell 145, 435–446, April 29, 2011 ª2011 Elsevier Inc.As a result, DNA replication starts with a low-nucleotide pool,
leading to replication stress and DNA damage. Our results indi-
cate that elevating the cellular nucleotide pool can rescue this
oncogene-induced replication stress, reduce DNA damage,
and decrease tumorigenicity of cells overexpressing these onco-
genes. In more advanced stages of cancer development, addi-
tional mechanisms likely lead to chromosomal instability, such
as telomere shortening, defective DNA damage repair, chromo-
somal segregation errors, and oxidative stress (Figure 5).
Disease progression in cancer is complex and multifactorial
and depends on acquiring adaptive mutations. In many cancers,
c-myc is highly expressed at a later stage in development
(Grandori et al., 2000). This leads to enhanced proliferation and
reduced DNA damage (Gordan et al., 2008). Apparently, high
expression of c-myc in advanced stages of cancer development
enables cells to proliferate more efficiently and increases the
tumorigenicity of the cells (Narisawa-Saito et al., 2008). Whereas
in many types of cancer, genomic instability may initiate with
uncoordinated cellular pathways leading to insufficient nucleo-
tides, in other cancers such as those with high expression of
c-myc at early stages, chromosomal instability may be caused
by other mechanisms.
The nucleotide pool is also affected by environmental factors
such as folate, which is an essential vitamin involved in the
metabolism of many cellular components, including the
synthesis of dTTP. Hence, proper levels of folate in the diet are
required for normal DNA replication (Rampersaud et al., 2002).
In recent years, many studies showed a correlation between
folate deficiency and the development of several types of
cancer, including HPV-induced cervical carcinoma (Garcı´a-
Closas et al., 2005; Rampersaud et al., 2002). Our replication
dynamics analysis showed that the expression of the HPV onco-
genes and cyclin E leads to insufficient nucleotide pool. Together
with a low folate intake, the replication is expected to be highly
perturbed. This may lead to an increased risk for carcinogenesis
due to a high rate of DSB formation and genomic instability.
In summary, replication stress and the resulting genomic
instability are prominent driving forces of early stages of cancer
development. Our results shed new light on the molecular basis
of oncogene-induced replication stress, showing that onco-
gene-induced cell proliferation may fail to achieve a sufficient
nucleotide pool to support normal DNA replication. Our results
suggest a new model of uncoordinated regulation of essential
pathways required for the production of a balanced level of cell
proliferation factors. This raises the possibility for the develop-
ment of new approaches for protection against precancerous
development.
EXPERIMENTAL PROCEDURES
Molecular Combing
Unsynchronized cells were pulse labeled for 30 min by medium containing
100 mM of the thymidine analog iododeoxyuridine (IdU). At the end of the first
labeling period, the cells were washed twice with a warm medium and pulse
labeled once more for 30 min with medium containing 100 mM of another
thymidine analog chlorodeoxyuridine (CldU). Cells were then harvested, and
genomic DNA was extracted, combed, and analyzed as previously described
(Herrick and Bensimon, 1999; Lebofsky et al., 2006). The primary antibody for
fluorescence detection of IdU was mouse anti-BrdU (Becton Dickinson), and
the secondary antibody was goat anti-mouse Alexa Fluor 488 (Invitrogen).
The primary antibody for fluorescence detection of CldU was rat anti-CldU
(Novus Biologicals). The secondary antibody was goat anti-rat Alexa Fluor
594 (Invitrogen). The length of the replication signals and the distances
between origins were measured in micrometers and converted to kilo bases
according to a constant and sequence-independent stretching factor
(1 mm = 2 Kb), as previously reported (Herrick and Bensimon, 1999).
Nucleotide Pool Analysis
Keratinocytes were harvested, and cellular nucleotides were extracted with
0.4 N perchloric acid and neutralized with potassium chloride. Deoxynucleoti-
des were separated from ribonucleotides using a boronate affinity column
(Shewach, 1992). Deoxynucleotides were analyzed by HPLC using UV absor-
bance at 254 and 281 nm for identification and quantitation as previously
described (Flanagan et al., 2007).
Soft Agar Assay
Following E6/E7 expression in primary keratinocytes, cells were grown in two
different growth conditions: (1) normal keratinocyte medium and (2) nucleo-
side-enriched medium (50 nM of A, U, C, and G). After 3–4 weeks, the cells
were trypsinized, and 250K cells were plated in 0.3% low gelling temperature
agarose (Agarose, Type VII, Sigma) to a final volume of 1ml per well; on the top
of the 3% agar layer, 0.5 ml medium was added (normal medium or enriched
with nucleosides). Colonies were counted after 4–6 weeks of growth.
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